These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33614771)

  • 1. A Multi-Institutional Retrospective Analysis of Toceranib Phosphate for Presumed or Confirmed Canine Aortic Body Chemodectomas.
    Coto GM; Musser ML; Tropf MA; Ward JL; Seo YJ; Mochel JP; Johannes CM
    Front Vet Sci; 2021; 8():635057. PubMed ID: 33614771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.
    Lew FH; McQuown B; Borrego J; Cunningham S; Burgess KE
    Vet Comp Oncol; 2019 Dec; 17(4):465-471. PubMed ID: 31069932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs.
    Berger EP; Johannes CM; Jergens AE; Allenspach K; Powers BE; Du Y; Mochel JP; Fox LE; Musser ML
    J Vet Intern Med; 2018 Nov; 32(6):2045-2053. PubMed ID: 30307656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective evaluation of toceranib phosphate (Palladia) in the treatment of canine carcinomatosis and mesothelioma.
    Hicks KA; Leeper HJ; Curran KM
    Vet Comp Oncol; 2024 Jun; 22(2):245-254. PubMed ID: 38622074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, multi-centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine nasal carcinoma.
    Ehling TJ; Klein MK; Smith L; Prescott D; Haney S; Looper J; LaDue T; Brawner W; Fidel J; Shiomitsu K; Green E; Saba C; Turek M; Farrelly J
    Vet Comp Oncol; 2022 Mar; 20(1):293-303. PubMed ID: 34655275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma.
    Musser ML; Johannes CM
    BMC Vet Res; 2021 Aug; 17(1):269. PubMed ID: 34380474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).
    Musser ML; Taikowski KL; Johannes CM; Bergman PJ
    BMC Vet Res; 2018 Sep; 14(1):272. PubMed ID: 30176869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caval chemodectoma in a cat.
    Martinez I; Brockman D; Purzycka K
    JFMS Open Rep; 2022; 8(2):20551169221106990. PubMed ID: 35811937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of toceranib phosphate (Palladia) use in cats with mast cell neoplasia.
    Berger EP; Johannes CM; Post GS; Rothchild G; Shiu KB; Wetzel S; Fox LE
    J Feline Med Surg; 2018 Feb; 20(2):95-102. PubMed ID: 29172873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009-2019).
    Sheppard-Olivares S; Bello NM; Johannes CM; Hocker SE; Biller B; Husbands B; Snyder E; McMillan M; McKee T; Wouda RM
    Vet Rec Open; 2022 Dec; 9(1):e27. PubMed ID: 35079406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of toceranib phosphate (Palladia) use in the treatment of feline pancreatic carcinoma.
    Rosario CO; Musser ML; Yuan L; Mochel JP; Talbott J; Johannes CM; Berger EP
    Can Vet J; 2023 Dec; 64(12):1143-1148. PubMed ID: 38046430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
    London CA; Malpas PB; Wood-Follis SL; Boucher JF; Rusk AW; Rosenberg MP; Henry CJ; Mitchener KL; Klein MK; Hintermeister JG; Bergman PJ; Couto GC; Mauldin GN; Michels GM
    Clin Cancer Res; 2009 Jun; 15(11):3856-65. PubMed ID: 19470739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma.
    Kim C; Matsuyama A; Mutsaers AJ; Woods JP
    Can Vet J; 2017 Oct; 58(10):1059-1064. PubMed ID: 28966355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced-stage canine nasal carcinomas with toceranib phosphate: 23 cases (2015-2020).
    Merino-Gutierrez V; Borrego JF; Puig J; Hernández A; Clemente-Vicario F
    J Small Anim Pract; 2021 Oct; 62(10):881-885. PubMed ID: 34131916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
    Wouda RM; Hocker SE; Higginbotham ML
    Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases (2013-2017).
    Elliott JW
    J Am Vet Med Assoc; 2019 Apr; 254(8):960-966. PubMed ID: 30938616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia
    Jang JK; Chretin J; Bruyette D; Hu P; Epstein AL
    J Cancer Sci Ther; 2015; 7(6):167-174. PubMed ID: 26635918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy for heart-base tumors in six dogs.
    Magestro LM; Gieger TL; Nolan MW
    J Vet Cardiol; 2018 Jun; 20(3):186-197. PubMed ID: 29724584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical/clinical trials of thrice-weekly administration of a combination of tegafur/gimeracil/oteracil (TS-1) and toceranib phosphate in dogs with intranasal tumors.
    Nishiyama Y; Maruo T; Fukuyama Y; Odaka Y; Kawata E; Ueno H; Kayanuma H; Nakayama T; Takahashi H
    J Vet Med Sci; 2024 Nov; 86(11):1129-1135. PubMed ID: 39358236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.